Sickle Cell Disease Treatment in Moradabad — Specialist Hematology Care at Jigyasa Hospital

Sickle cell disease is one of the oldest and most widespread inherited blood disorders in the world, and India carries a major part of its burden. Yet many families across Uttar Pradesh still face late diagnosis, repeated complications, avoidable hospitalisations, and preventable organ damage because specialist care is often not accessed early enough.
At Jigyasa Hospital, Moradabad, Dr. Faran Naim brings evidence-based hematology care directly to patients across Moradabad, Rohilkhand, and western Uttar Pradesh. His approach covers not just diagnosis, but long-term disease modification, prevention, and complication monitoring.
From accurate haemoglobin testing and hydroxyurea therapy to emergency pain-crisis care, transfusion planning, infection prevention, family screening, and bone marrow transplant evaluation, specialist sickle cell disease care is now available much closer to home.
Accurate Sickle Cell Diagnosis
Structured diagnosis with CBC, peripheral smear, HPLC or haemoglobin electrophoresis, and genotype-specific classification.
Hydroxyurea Therapy
Specialist initiation and monitoring of hydroxyurea to reduce pain crises, transfusion need, and long-term complications.
Pain Crisis Management
Prompt inpatient and emergency care for vaso-occlusive crisis, acute chest syndrome, severe anaemia, and related complications.
Stroke and Organ Protection
Monitoring for stroke risk, kidney disease, pulmonary hypertension, retinopathy, growth delay, and chronic organ damage.
Blood Transfusion Support
Episodic and chronic transfusion planning for severe anaemia, stroke prevention, and high-risk clinical situations.
Family Screening and BMT Planning
Genetic counselling, family haemoglobin testing, and bone marrow transplant evaluation for eligible children and young adults.
Understanding Sickle Cell Disease
Sickle cell disease is an inherited disorder of the red blood cells caused by a mutation in the gene responsible for producing haemoglobin. This mutation leads to the production of abnormal haemoglobin S, or HbS, instead of normal haemoglobin.
Normal red blood cells are round, flexible, and able to move smoothly through blood vessels. In sickle cell disease, red cells become rigid, sticky, and crescent-shaped under low-oxygen conditions. These abnormal cells do not travel properly and can damage tissues in multiple ways.
The disease causes chronic haemolytic anaemia because sickled red cells break down far faster than normal cells, surviving only a small fraction of the normal lifespan. At the same time, these cells block blood vessels and reduce blood flow, triggering painful vaso-occlusive crises and repeated tissue injury.
Over time, this combination of anaemia and vascular blockage can affect nearly every organ system in the body, which is why sickle cell disease needs long-term specialist management rather than only crisis-based treatment.
Symptoms and Complications of Sickle Cell Disease
The most common acute complication is the vaso-occlusive pain crisis, in which sickled cells block small blood vessels and cause sudden severe pain in the limbs, chest, back, or abdomen. Acute chest syndrome is another major emergency and can present with chest pain, breathlessness, fever, and falling oxygen levels.
Children may also face splenic sequestration, aplastic crisis, severe infections, and even stroke. Silent strokes can occur without obvious symptoms but still affect long-term brain function, which is why stroke-risk screening is so important in pediatric care.
Chronic complications include avascular necrosis of the hip or shoulder, chronic kidney disease, pulmonary hypertension, retinopathy, leg ulcers, delayed growth and puberty, and persistent chronic pain. Many of these complications evolve gradually and need active monitoring rather than waiting for obvious symptoms.
The wide range of complications makes it clear that sickle cell disease is not just an anaemia disorder. It is a whole-body vascular and hematological disease that requires proactive, specialist-led follow-up.
How Is Sickle Cell Disease Diagnosed?
Diagnosis begins with basic blood testing. A Complete Blood Count often shows chronic anaemia, and the reticulocyte count is commonly raised because the bone marrow is trying to replace red cells that are being destroyed too quickly.
A peripheral blood smear may reveal sickle-shaped red blood cells, target cells, and related abnormalities. However, the definitive diagnosis is made through haemoglobin electrophoresis or HPLC, which identifies and quantifies haemoglobin fractions such as HbS, HbA, HbF, and HbC and allows accurate genotype classification.
Screening tests such as the solubility test may suggest the presence of HbS, but they cannot distinguish between sickle cell trait and sickle cell disease. Confirmatory haemoglobin separation testing is therefore essential in every positive case.
Once diagnosis is established, Dr. Faran Naim also evaluates kidney function, liver function, heart health, eye health, and stroke risk. In children, annual transcranial Doppler screening is particularly important to identify those at high risk of stroke before it happens.
Sickle Cell Disease Treatment at Jigyasa Hospital
Treatment has two major goals: long-term disease modification and acute crisis management. The most important disease-modifying medicine is hydroxyurea, which increases foetal haemoglobin and reduces the concentration and harmful behaviour of haemoglobin S inside red blood cells.
With proper monitoring, hydroxyurea can reduce the frequency and severity of pain crises, decrease acute chest syndrome episodes, lower transfusion requirements, reduce hospitalisation, and improve overall quality of life. Dr. Faran Naim starts and monitors hydroxyurea therapy carefully in both children and adults where appropriate.
Blood transfusions are used in two ways. Episodic transfusions help manage severe anaemia, acute chest syndrome, stroke, splenic sequestration, or major surgery preparation. Chronic transfusion programmes are reserved for patients at high stroke risk or with a prior stroke, with careful monitoring for iron overload and the need for chelation.
Supportive treatment also includes folic acid supplementation, vaccination, daily penicillin prophylaxis in young children, oxygen and hydration when needed, infection treatment, and emergency pain control using proper analgesic protocols during vaso-occlusive crises.
Management of Specific Complications
Sickle cell disease complications often need multidisciplinary care. Dr. Faran Naim manages avascular necrosis with pain control, rehabilitation guidance, and orthopedic referral when needed. Kidney disease, pulmonary hypertension, and chronic anaemia require close long-term surveillance and organ-specific treatment strategies.
Eye complications such as sickle retinopathy require specialist ophthalmology review, while priapism in male patients needs urgent treatment to prevent permanent damage. Leg ulcers, chronic infections, delayed growth, and endocrine complications also need coordinated management.
In children, early diagnosis matters even more. Dactylitis, recurrent fever, unexplained anaemia, delayed growth, or sudden enlargement of the spleen may all be early warning signs. Early identification allows vaccination, penicillin prophylaxis, and disease-modifying therapy to begin before serious complications develop.
Families with known sickle trait or affected children should also consider family haemoglobin testing and genetic counselling so that future risk can be understood clearly and managed responsibly.
Why Choose Dr. Faran Naim and Jigyasa Hospital?
Sickle cell disease is lifelong and requires a long-term relationship with a specialist who understands the disease in detail. Dr. Faran Naim brings that hematology expertise to Moradabad, reducing the need for repeated travel to metro cities for essential follow-up and emergency decisions.
His approach begins with precise genotype-specific diagnosis using proper haemoglobin testing and continues through hydroxyurea prescribing, regular monitoring, complication screening, acute crisis management, and transfusion planning. This helps ensure that patients are treated based on the exact disease pattern they have, not with a generic approach.
Jigyasa Hospital also supports inpatient crisis care, infection prevention strategies, family screening, and bone marrow transplant evaluation for selected children and young adults with severe disease. This continuity is especially valuable for families needing frequent review.
Early specialist involvement is often the most important step in preventing avoidable complications. With Dr. Faran Naim at Jigyasa Hospital, families in Moradabad and surrounding areas can now access structured sickle cell care much closer to home.
Patient Experiences
“My brother had repeated pain crises and frequent admissions before we met Dr. Faran Naim. With proper diagnosis, hydroxyurea, and structured follow-up, his condition is much better controlled and our family finally understands how to manage the disease.”
Shivani R.
Moradabad - Hydroxyurea and Sickle Cell Follow-up
“During a severe pain crisis, we were extremely scared. Dr. Naim and the Jigyasa Hospital team treated him quickly and explained every complication we needed to watch for. We now have a much clearer long-term plan.”
Aslam K.
Rampur - Pain Crisis Management
“Our child had recurring weakness, fever, and pain episodes that were not being understood properly. Dr. Faran Naim guided us through the correct tests, treatment options, and future screening. The clarity and confidence he gave us meant a lot.”
Pooja S.
Bijnor - Childhood Sickle Cell Evaluation
Book Your Consultation with Dr. Faran Naim
If you or your child has sickle cell disease, early specialist involvement can make a major difference to long-term health, growth, organ protection, and quality of life. Jigyasa Hospital now offers dedicated hematology care for patients across Moradabad and surrounding districts.
Book your consultation with Dr. Faran Naim today for accurate diagnosis, hydroxyurea planning, crisis management guidance, family screening, and evaluation of long-term treatment options including bone marrow transplant where appropriate.
Address
Near Miglani Cinema, Rampur Road, Moradabad 244001
Sickle Cell Disease Appointments and Enquiries
+91-7900903333Frequently Asked Questions — Sickle Cell Disease Treatment in Moradabad
Is sickle cell disease common in Uttar Pradesh?
Yes. Sickle cell disease is documented across Uttar Pradesh, with cases reported particularly among communities with a history of the condition in their ancestry.
Can sickle cell disease be cured?
Yes. The only currently available curative treatment is allogeneic bone marrow transplant. This replaces the patient's bone marrow stem cells with healthy donor cells, eliminating the source of abnormal haemoglobin S production.
What is hydroxyurea and is it safe for children with sickle cell disease?
Hydroxyurea is a disease-modifying therapy that increases foetal haemoglobin levels, reducing haemoglobin S polymerisation, haemolysis, and the frequency of vaso-occlusive crises. It is approved in India for sickle cell anaemia and is considered safe and effective in children when prescribed and monitored by a specialist.
How often will a sickle cell patient need follow-up?
Stable patients on hydroxyurea usually need review every 2 to 3 months for blood count monitoring and clinical assessment. More frequent follow-up is needed after a pain crisis, during treatment changes, or for patients on chronic transfusion programmes. Children also require annual transcranial Doppler screening and growth monitoring.
What should a sickle cell patient in Moradabad do during a pain crisis?
A severe pain crisis should be evaluated promptly at Jigyasa Hospital's emergency department. Patients should not remain at home with inadequate pain control because untreated crises can worsen, and serious complications such as acute chest syndrome may develop quickly.
How is sickle cell disease confirmed?
Definitive diagnosis is made through haemoglobin electrophoresis or HPLC, which identifies and quantifies abnormal haemoglobin types such as HbS. CBC, peripheral smear, and other organ-function tests support diagnosis and long-term monitoring.
Why Patients Choose Us
- 24/7 Emergency & Trauma Care
- Top Specialist Doctors
- Modern ICU & Operation Theatres
- Transparent & Affordable Pricing
- Ayushman Bharat Empanelled
- Cashless Insurance Support
- Multispeciality Under One Roof
Our Location
Near Miglani Cinema,
Rampur Road,
Moradabad 244001

